Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:03 PM
Ignite Modification Date:
2025-12-26 @ 4:03 PM
NCT ID:
NCT01555606
Eligibility Criteria:
Inclusion Criteria:
Adult male and female patients having diagnosis of plaque psoriasis for at least 6 months prior to screening
* Patients who are candidates for or are currently receiving the following: a. conventional systemic agents (eg, MTX, acitretin, cyclosporine, fumarates, or systemic psoralens plus ultraviolet A light \[PUVA\]), b. topical therapy and/or phototherapy (and are eligible for, but are not currently receiving oral systemic or biologic therapy), c. biologic therapy for moderate to severe plaque psoriasis
* Have a peak historical or current physician's global assessment (PGA) of greater than or equal to 3 (range 0-5)
* Patients must have the ability to read and speak English
* Patients must reside in the US.
Exclusion Criteria:
Patients with guttate, erythrodermic, or pustular psoriasis (all are various types of psoriasis)
\- Patients with serious concomitant illness that could require the use of systemic corticosteroids or otherwise interfere with the patient's participation in the trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01555606
Study Brief:
Protocol Section:
NCT01555606